O'Hare, Ann M <br/><br/>
Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults.  [electronic resource] 

 -  JAMA internal medicine  Mar 2014 
 - 391-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6114 
<br/><br/><label>Standard No.: </label>10.1001/jamainternmed.2013.13328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Clinical Trials as Topic<br/>Computer Simulation<br/>Female<br/>Glomerular Filtration Rate--drug effects<br/>Humans<br/>Kidney Failure, Chronic--drug therapy<br/>Male<br/>Outcome Assessment, Health Care<br/>Retrospective Studies<br/>Risk Factors<br/>United States